Inventor · disambiguated record
Yoshikazu Yonemitsu
Also filed as: YONEMITSU YOSHIKAZU
15 granted patents·21 pending applications·91 citations·filing 2000–2025
92Inventor score
Top patents by PatentIndex Score
36 records- 0185US9127256B2Method for production of reprogrammed cell using chromosomally unintegrated virus vectorFUSAKI NOEMI·Filed 2009·Granted Sep 8, 2015·9 cites·4 claims
- 0284US7510706B2Pseudotype retroviral vectors containing membrane proteins having hemagglutinin activityDNAVEC RESEARCH INC·Filed 2002·Granted Mar 31, 2009·24 cites·54 claims
- 0383US7314614B1Recombinant sendai virus vector for introducing exogenous genes to airway epitheliaDNAVEC RESEARCH INC·Filed 2000·Granted Jan 1, 2008·17 cites·17 claims
- 0482US9404083B2Method for amplifying NK cellsYONEMITSU YOSHIKAZU·Filed 2012·Granted Aug 2, 2016·10 cites·18 claims
- 0582US8283163B2Method for production of dendritic cellINOUE MAKOTO·Filed 2008·Granted Oct 9, 2012·2 cites·8 claims
- 0681US11136594B2Method for production of reprogrammed cell using chromosomally unintegrated virus vectorID PHARMA CO LTD·Filed 2016·Granted Oct 5, 2021·2 cites·6 claims
- 0780US8889118B2Anticancer agent containing dendritic cell having RNA virus transferred thereintoOKANO SHINJI·Filed 2005·Granted Nov 18, 2014·12 cites·18 claims
- 0879US11987812B2Population of CD3-negative cells that express chemokine receptor and cell adhesion molecule, use of the same, and method for producing the sameGAIA BIOMEDICINE INC·Filed 2019·Granted May 21, 2024·2 cites·12 claims
- 0978US8741639B2Method for producing dendritic cellsYONEMITSU YOSHIKAZU·Filed 2009·Granted Jun 3, 2014·3 cites·5 claims
- 1075US2024254446A1Population of CD3-negative cells that express chemokine receptor and cell adhesion molecule, use of the same, and method for producing the sameYONEMITSU YOSHIKAZU·Filed 2024·Application pending·0 cites
- 1174US12329817B2Highly active NK cell and use thereofYONEMITSU YOSHIKAZU·Filed 2023·Granted Jun 17, 2025·0 cites·7 claims
- 1274US8278284B2Therapeutic agents for diseases associated with apoptotic degeneration in ocular tissue cells that use SIV-PEDF vectorsMIYAZAKI MASANORI·Filed 2006·Granted Oct 2, 2012·5 cites·7 claims
- 1371US9695445B2Method for production of reprogrammed cell using chromosomally unintegrated virus vectorDNAVEC CORP·Filed 2015·Granted Jul 4, 2017·1 cites·10 claims
- 1463US11723924B2Highly active NK cell and use thereofYONEMITSU YOSHIKAZU·Filed 2018·Granted Aug 15, 2023·0 cites·12 claims
- 1562US7309693B2Preventives and remedies for pulmonary hypertensionKENSUKE EGASHIRA·Filed 2001·Granted Dec 18, 2007·4 cites·4 claims
- 1660US2025161454A1Highly active nk cell and use thereofYONEMITSU YOSHIKAZU·Filed 2025·Application pending·0 cites
- 1756US2010158867A1Paramyxovirus vector encoding angiogenesis gene and use thereofDNAVEC RESEARCH INC·Filed 2009·Application pending·0 cites
- 1854US2024366673A1Method for treating cellsGAIA BIOMEDICINE INC·Filed 2022·Application pending·0 cites
- 1949US2023256019A1Method for stabilizing binding of nk cell and antibody, and use thereofGAIA BIOMEDICINE INC·Filed 2021·Application pending·0 cites
- 2049US2008199438A1Methods For Suppressing Tumor ProliferationDNAVEC RESEARCH INC·Filed 2005·Application pending·0 cites
- 2148US2022184122A1A method for providing immune cellsYONEMITSU YOSHIKAZU·Filed 2020·Application pending·0 cites
- 2247US2021000871A1Method for producing a cell population including nk cellsGAIA BIOMEDICINE INC·Filed 2020·Application pending·0 cites
- 2347US2023109717A1Method for treating highly active nk cellsGAIA BIOMEDICINE INC·Filed 2021·Application pending·0 cites
- 2446US8211868B2Paramyxovirus vector encoding angiogenesis gene and use thereofYONEMITSU YOSHIKAZU·Filed 2011·Granted Jul 3, 2012·0 cites·22 claims
- 2545US2007269414A1Method for Producing Gene Transferred Denritic CellsOKANO SHINJI·Filed 2004·Application pending·0 cites
- 2644US2003170210A1Use of paramyxovirus vector in gene transfer into blood vesselFiled 2001·Application pending·0 cites
- 2744US2006104950A1Methods of Tranducing genes into T cellsOKANO SHINJI·Filed 2003·Application pending·0 cites
- 2843US2020061276A1Extracorporeal artificial liver and device for extracorporeal artificial liver or culture of hepatocytesYONEMITSU YOSHIKAZU·Filed 2018·Application pending·0 cites
- 2942US2019055590A1Regularly arranged spheroids having equal sizes and use thereofYONEMITSU YOSHIKAZU·Filed 2017·Application pending·0 cites
- 3041US2004005296A1Paramyxovirus vector encoding angiogenesis gene and use thereofFiled 2003·Application pending·0 cites
- 3141US2019194614A1A method for preparing mononuclear cellsYONEMITSU YOSHIKAZU·Filed 2017·Application pending·0 cites
- 3241US2019062699A1Highly functional hepatocyte and use thereofYONEMITSU YOSHIKAZU·Filed 2017·Application pending·0 cites
- 3341US2007173466A1Methods of treating inflammatory diseases associated with bone destructionSUEISHI KATSUO·Filed 2004·Application pending·0 cites
- 3440US2016097035A1Method for preparing nk cellsUNIV KYUSHU NAT UNIV CORP·Filed 2014·Application pending·0 cites
- 3540US2009170798A1Highly safe intranasally administrable gene vaccines for treating alzheimer's diseaseJAPAN GOVERNMENT·Filed 2006·Application pending·0 cites
- 3639US2019194597A1A device for aseptically treating a suspensionYONEMITSU YOSHIKAZU·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Yoshikazu Yonemitsu files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →